Sign In
Pharma
Aurobindo unit's Andhra plant receives 1 observation from USFDA
Aurobindo Pharma Q1 net at Rs 571 cr
Aurobindo Pharma gets USFDA approval for Sevelamer hydrochloride tablets
Aurobindo Pharma holds graduation ceremony of its staff
Industry
Aurobindo Pharma’s arm ink deal with MPP to develop cancer drug
Aurobindo Pharma Q4 profit at `506 cr on stable demand
Indian pharma sector set for 'volume to value leadership' journey in 2023
Aurobindo Pharma inks pact with IMT Hyderabad
3 Indian pharma majors recalling products in US
Hyderabad based Aurobindo Pharma acquires Veritaz Healthcare
Aurobindo's Molnaflu for Covid treatment
Economy
Aurobindo, Unichem recall products in US
